H.C. Wainwright Downgrades Inhibikase Therapeutics Inc (IKT) to Neutral

February 12, 2025 6:04 AM EST Send to a Friend
H.C. Wainwright analyst Ed White downgraded Inhibikase Therapeutics Inc (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login